Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Screening for retinopathy in children with type 1 diabetes in Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bone turnover markers in children and adolescents with type 1 diabetes - A systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  1. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Leukocyte telomere length is associated with elevated plasma glucose and HbA1c in young healthy men independent of birth weight

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Perinatal Whole Blood Zinc Status and Cytokines, Adipokines, and Other Immune Response Proteins

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Bone turnover markers in children and adolescents with type 1 diabetes - A systematic review

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Background/Objective: Children with type 1 diabetes (T1D) are screened regularly for retinopathy with fundus photography to prevent visual impairment. According to Danish national guidelines, screening should take place at age 12, 15, and 18 years after minimum 3 years of diabetes. As glycemic control has improved, prevalence of retinopathy is expected to be decreased. The aim of this study is to investigate the prevalence, degree, and progression of retinopathy in children with T1D and to explore if screening at 12 years is currently indicated in Denmark. Methods: Data on all Danish children with onset of T1D from 2003 to 2013 (n = 2943) were collected from the “DanDiabKids” registry. For children with registered screenings (n = 2382), prevalence of retinopathy at 12, 15, and 18 years was determined. In children with retinopathy, subsequent screenings were studied to reveal if retinopathy was persistent or temporary. Results: Prevalence of retinopathy at 12, 15, and 18 years was 0.9%, 2.3%, and 3.1%, respectively. Minimal background retinopathy was seen in over 90% and 100% at 12 years. In available re-screenings, retinopathy resolved spontaneously in 87.5% of all cases and 100% of cases at 12 years. Conclusions: The prevalence of retinopathy in Danish children with T1D was low. At 12 years, prevalence was 0.9% and exclusively minimal background retinopathy with 100% remission in re-screenings. Thus, screening at this age does not seem to have significant clinical relevance. We propose more individualized screening selection before the age of 15.

Original languageEnglish
JournalPediatric Diabetes
Volume21
Pages (from-to)106-111
ISSN1399-543X
DOIs
Publication statusPublished - 2020

Bibliographical note

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

    Research areas

  • adolescents, children, diabetes, retinopathy

ID: 58153800